Scott S. Billecke
- Clinical Biochemistry top 0.1%
- Plant Science top 2%
- Biochemistry top 0.5%
- Pharmacology top 2%
- Molecular Biology
- Co-authors
- Bert N. La DuRobert C. SorensonMichael AviramCharles L. BisgaierCary HsuDragomir DraganovRoger S. NewtonMira Rosenblat
- Topics
- Paraoxonase enzyme and polymorphisms (12 papers)Nitric Oxide and Endothelin Effects (7 papers)Biochemical Acid Research Studies (6 papers)
- Journals
- Journal of Biological ChemistryFree Radical Biology and MedicineArteriosclerosis Thrombosis and Vascular Biology
- Partner nations
- United StatesIsraelJapan
In The Last Decade
Scott S. Billecke
30 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Clinical Biochemistry 1.8k
- Plant Science 927
- Biochemistry 605
- Pharmacology 523
- Molecular Biology 459
Countries citing papers authored by Scott S. Billecke
This map shows the geographic impact of Scott S. Billecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott S. Billecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott S. Billecke more than expected).
Fields of papers citing papers by Scott S. Billecke
This network shows the impact of papers produced by Scott S. Billecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott S. Billecke. The network helps show where Scott S. Billecke may publish in the future.
Co-authorship network of co-authors of Scott S. Billecke
This figure shows the co-authorship network connecting the top 25 collaborators of Scott S. Billecke. A scholar is included among the top collaborators of Scott S. Billecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott S. Billecke. Scott S. Billecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 33 | |
| 3 | 3 | |
| 4 | 36 | |
| 5 | 31 | |
| 6 | 21 | |
| 7 | 32 | |
| 8 | 35 | |
| 9 | 39 | |
| 10 | 39 | |
| 11 | 51 | |
| 12 | 265 | |
| 13 | 266 | |
| 14 | 157 | |
| 15 | 15 | |
| 16 | 2 | |
| 17 | 12 | |
| 18 | 30 | |
| 19 | Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidantsbreakdown → | 523 |
| 20 | 141 |
About Scott S. Billecke
Scott S. Billecke is a scholar working on Clinical Biochemistry, Biochemistry and Complementary and Manual Therapy, having authored 30 papers that have together received 2.6k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (12 papers), Nitric Oxide and Endothelin Effects (7 papers) and Biochemical Acid Research Studies (6 papers). The work is most often cited by research in Clinical Biochemistry (1.8k citations), Biochemistry (605 citations) and Pharmacology (298 citations). Scott S. Billecke has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Bert N. La Du, Robert C. Sorenson, Michael Aviram, Charles L. Bisgaier, Cary Hsu, Dragomir Draganov, Roger S. Newton, Mira Rosenblat, Catherine E. Watson and Philip L. Stetson. Their work appears in journals such as Journal of Biological Chemistry, Free Radical Biology and Medicine and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.